HomeCompareMOHOY vs JNJ

MOHOY vs JNJ: Dividend Comparison 2026

MOHOY yields 16000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MOHOY wins by $5739399895121922048.00M in total portfolio value
10 years
MOHOY
MOHOY
● Live price
16000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5739399895121922048.00M
Annual income
$5,669,692,746,486,511,000,000,000.00
Full MOHOY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — MOHOY vs JNJ

📍 MOHOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMOHOYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MOHOY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MOHOY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MOHOY
Annual income on $10K today (after 15% tax)
$1,360,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,819,238,834,513,534,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, MOHOY beats the other by $4,819,238,834,513,534,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MOHOY + JNJ for your $10,000?

MOHOY: 50%JNJ: 50%
100% JNJ50/50100% MOHOY
Portfolio after 10yr
$2869699947560961024.00M
Annual income
$2,834,846,373,243,255,500,000,000.00/yr
Blended yield
98.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MOHOY
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MOHOY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMOHOYJNJ
Forward yield16000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$5739399895121922048.00M$30.3K
Annual income after 10y$5,669,692,746,486,511,000,000,000.00$4,689.40
Total dividends collected$5734790714114983936.00M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MOHOY vs JNJ ($10,000, DRIP)

YearMOHOY PortfolioMOHOY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,610,700$1,600,000.00$10,592$272.30+$1.60MMOHOY
2$242,575,785$240,852,336.45$11,289$357.73+$242.56MMOHOY
3$34,159,569,779$33,900,013,688.34$12,123$472.89+$34159.56MMOHOY
4$4,498,052,225,409$4,461,501,485,745.83$13,141$629.86+$4498052.21MMOHOY
5$553,859,716,889,880$549,046,801,008,692.06$14,408$846.81+$553859716.88MMOHOY
6$63,775,721,659,507,620$63,183,091,762,435,450.00$16,021$1,151.60+$63775721659.49MMOHOY
7$6,867,673,013,551,547,000$6,799,432,991,375,874,000.00$18,122$1,588.22+$6867673013551.53MMOHOY
8$691,643,065,570,419,700,000$684,294,655,445,919,500,000.00$20,930$2,228.20+$691643065570419.63MMOHOY
9$65,146,867,883,561,620,000,000$64,406,809,803,401,275,000,000.00$24,792$3,191.91+$65146867883561624.00MMOHOY
10$5,739,399,895,121,922,000,000,000$5,669,692,746,486,511,000,000,000.00$30,274$4,689.40+$5739399895121922048.00MMOHOY

MOHOY vs JNJ: Complete Analysis 2026

MOHOYStock

ECMOHO Limited, an investment holding company, operates as an integrated solution provider in the health and wellness market. The company offers health supplements and food, mother and child care products, personal care products, and household healthcare equipment and cleaning products. It sells its products through flagship stores of its brand partners, self-operated branded stores on third-party e-commerce platforms; and other small and medium-sized online and offline retailers. The company is also involved in the provision of bonded area warehousing; online store operating services; and promotion and marketing services to its brand partners and other brand customers. It serves consumers and retailers. The company was founded in 2011 and is headquartered in Shanghai, the People's Republic of China.

Full MOHOY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MOHOY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MOHOY vs SCHDMOHOY vs JEPIMOHOY vs OMOHOY vs KOMOHOY vs MAINMOHOY vs ABBVMOHOY vs MRKMOHOY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.